TABLE 1.
Pre-LAS (n = 3729) (%) | Post-LAS (n = 4362) (%) | P value* | |
---|---|---|---|
Age (mean ± SD) | 49.1 ± 14.7 | 51.3 ± 14.9 | .60 |
Gender (male) | 1906 (51.1) | 2504 (57.4) | <.001 |
Creatinine | 0.93 | 0.87 | .002 |
Cerebrovascular disease | 25 (0.7) | 21 (0.9) | .06 |
Peripheral vascular disease | 40 (1.1) | 25 (1.1) | .97 |
History of cigarette use | 335 (58.6) | 2386 (60.9) | .28 |
History of malignancy | 121 (3.2) | 250 (5.7) | <.0001 |
Diagnosis | <.0001 | ||
COPD | 1384 (37.1) | 1241 (28.5) | |
Pulmonary fibrosis | 790 (21.2) | 1293 (29.6) | |
Cystic fibrosis | 598 (16.0) | 621 (14.2) | |
Alpha-1 antitrypsin deficiency | 220 (5.9) | 129 (3.0) | |
Pulmonary hypertension | 137 (3.7) | 87 (2.0) | |
Bronchi ectasis | 78 (2.1) | 75 (1.7) | |
Days on waiting list (mean ± SD) | 436.2 ± 455.8 | 263.4 ± 448.7 | <.0001 |
Transplant type | |||
Single | 1682 (45.2) | 1616 (37.1) | <.0001 |
Double | 2043 (54.8) | 2745 (62.9) | |
Ischemic time (h) (mean ± SD) | 4.7 ± 1.7 | 5.1 ± 1.7 | <.0001 |
SD, Standard deviation; COPD, chronic obstructive pulmonary disease.
Significance P < .05.